These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11740725)

  • 1. Cervical coinfection with human papillomavirus (HPV) types as a predictor of acquisition and persistence of HPV infection.
    Rousseau MC; Pereira JS; Prado JC; Villa LL; Rohan TE; Franco EL
    J Infect Dis; 2001 Dec; 184(12):1508-17. PubMed ID: 11740725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women's Health Study.
    Giuliano AR; Harris R; Sedjo RL; Baldwin S; Roe D; Papenfuss MR; Abrahamsen M; Inserra P; Olvera S; Hatch K
    J Infect Dis; 2002 Aug; 186(4):462-9. PubMed ID: 12195372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types.
    Liaw KL; Hildesheim A; Burk RD; Gravitt P; Wacholder S; Manos MM; Scott DR; Sherman ME; Kurman RJ; Glass AG; Anderson SM; Schiffman M
    J Infect Dis; 2001 Jan; 183(1):8-15. PubMed ID: 11087198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M; Garbuglia AR; Benedetto A; Cappiello T; Leoncini L; Migliore G; Agarossi A; Syrjänen K;
    Int J STD AIDS; 2003 Jun; 14(6):417-25. PubMed ID: 12816671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer.
    Franco EL; Villa LL; Sobrinho JP; Prado JM; Rousseau MC; Désy M; Rohan TE
    J Infect Dis; 1999 Nov; 180(5):1415-23. PubMed ID: 10515798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and genotype distribution of multiple human papillomavirus infection in the uterine cervix: a 7.5-year longitudinal study in a routine cytology-based screening population in West Germany.
    Kovács K; Varnai AD; Bollmann M; Bankfalvi A; Szendy M; Speich N; Schmitt C; Pajor L; Bollmann R
    J Med Virol; 2008 Oct; 80(10):1814-23. PubMed ID: 18712836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.
    Rousseau MC; Franco EL; Villa LL; Sobrinho JP; Termini L; Prado JM; Rohan TE
    Cancer Epidemiol Biomarkers Prev; 2000 May; 9(5):469-76. PubMed ID: 10815691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent and sequential acquisition of different genital human papillomavirus types.
    Thomas KK; Hughes JP; Kuypers JM; Kiviat NB; Lee SK; Adam DE; Koutsky LA
    J Infect Dis; 2000 Oct; 182(4):1097-102. PubMed ID: 10979905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types.
    Castle PE; Schiffman M; Burk RD; Wacholder S; Hildesheim A; Herrero R; Bratti MC; Sherman ME; Lorincz A
    Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1394-9. PubMed ID: 12433717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus type-distribution in the cervix of Chinese women: a meta-analysis.
    Bao YP; Li N; Smith JS; Qiao YL
    Int J STD AIDS; 2008 Feb; 19(2):106-11. PubMed ID: 18334063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type distribution among women with cervical pathology - a study over 4 years at Jimma Hospital, southwest Ethiopia.
    Bekele A; Baay M; Mekonnen Z; Suleman S; Chatterjee S
    Trop Med Int Health; 2010 Aug; 15(8):890-3. PubMed ID: 20545913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of human papillomavirus types 6, 11, 16, 18, 31, and 33 in a cohort of Greek women.
    Panotopoulou E; Tserkezoglou A; Kouvousi M; Tsiaousi I; Chatzieleftheriou G; Daskalopoulou D; Magiakos G
    J Med Virol; 2007 Dec; 79(12):1898-905. PubMed ID: 17935171
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clearance, persistence and recurrence of HPV infection].
    Denis F; Hanz S; Alain S
    Gynecol Obstet Fertil; 2008 Apr; 36(4):430-40. PubMed ID: 18417407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Detection and molecular typing of human papillomaviruses: prevalence of cervical infection in the Tunisian central region].
    Hassen E; Remadi S; Chouchane L
    Tunis Med; 1999 Oct; 77(10):497-502. PubMed ID: 10670281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical coinfection with human papillomavirus (HPV) types and possible implications for the prevention of cervical cancer by HPV vaccines.
    Mendez F; Munoz N; Posso H; Molano M; Moreno V; van den Brule AJ; Ronderos M; Meijer C; Munoz A;
    J Infect Dis; 2005 Oct; 192(7):1158-65. PubMed ID: 16136457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.
    Moscicki AB; Ellenberg JH; Farhat S; Xu J
    J Infect Dis; 2004 Jul; 190(1):37-45. PubMed ID: 15195241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study.
    Roteli-Martins CM; de Carvalho NS; Naud P; Teixeira J; Borba P; Derchain S; Tyring S; Gall S; Diaz A; Blatter M; Shier RM; Romanowski B; Quint WG; Issam J; Galindo C; Schuind A; Dubin G
    Int J Gynecol Pathol; 2011 Mar; 30(2):173-84. PubMed ID: 21293281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women.
    Insinga RP; Perez G; Wheeler CM; Koutsky LA; Garland SM; Leodolter S; Joura EA; Ferris DG; Steben M; Brown DR; Elbasha EH; Paavonen J; Haupt RM;
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1585-94. PubMed ID: 20530494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus type specific DNA and RNA persistence--implications for cervical disease progression and monitoring.
    Cuschieri KS; Whitley MJ; Cubie HA
    J Med Virol; 2004 May; 73(1):65-70. PubMed ID: 15042650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of cervical infection with multiple human papillomavirus types is associated with age and cytologic abnormalities.
    Rousseau MC; Villa LL; Costa MC; Abrahamowicz M; Rohan TE; Franco E
    Sex Transm Dis; 2003 Jul; 30(7):581-7. PubMed ID: 12838088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.